1. Home
  2. FUL vs ARQT Comparison

FUL vs ARQT Comparison

Compare FUL & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H. B. Fuller Company

FUL

H. B. Fuller Company

HOLD

Current Price

$63.38

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$30.12

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUL
ARQT
Founded
1887
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FUL
ARQT
Price
$63.38
$30.12
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$68.50
$24.83
AVG Volume (30 Days)
341.4K
1.8M
Earning Date
01-14-2026
02-24-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$3,502,085,000.00
$317,929,000.00
Revenue This Year
N/A
$85.51
Revenue Next Year
$1.91
$30.74
P/E Ratio
$29.57
N/A
Revenue Growth
N/A
129.21
52 Week Low
$47.56
$11.13
52 Week High
$65.36
$31.77

Technical Indicators

Market Signals
Indicator
FUL
ARQT
Relative Strength Index (RSI) 65.91 57.63
Support Level $59.36 $28.75
Resistance Level $62.00 $30.60
Average True Range (ATR) 1.36 1.22
MACD 0.16 -0.04
Stochastic Oscillator 94.58 82.16

Price Performance

Historical Comparison
FUL
ARQT

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: